Intensive pharmacologic treatment in patients with acute non ST-segment elevation myocardial infarction who did not undergo percutaneous coronary intervention

Circulation Journal : Official Journal of the Japanese Circulation Society
Hae Chang JeongKorea Acute Myocardial Infarction Registry Investigators

Abstract

The aim of this study was to assess the impact of more aggressive pharmacological treatment on short-term clinical outcomes in patients with acute non ST-segment elevation myocardial infarction (NSTEMI) who do not undergo percutaneous coronary intervention (PCI). The 924 NSTEMI patients treated with early conservative strategy (69.2+/-12.5 years, 637 males) in 50 hospitals that were high-volume centers with facilities for primary PCI were recruited to the Korean Acute Myocardial Infarction Registry (KAMIR) from November 2005 to August 2007. For all patients, the pharmacotherapy index based on the use of drugs during hospital stay was assessed (range of points 0-10). Primary endpoint was the combined in-hospital mortality and morbidity and major adverse cardiac events during 1 month of clinical follow-up. Of the patients, data from 847 who were followed-up for 1 month after discharge were analyzed. The rate of the primary endpoint decreased with an increase of the pharmacotherapy index and this result was similar in the low- and high-risk groups. In the multivariate analysis, low pharmacotherapy index (<or=4 points) was an independent predictor of the primary endpoint. More intensive pharmacological treatment may improve short-t...Continue Reading

Associated Clinical Trials

References

Jan 1, 1976·Birth Defects Original Article Series·F H Ruddle, P Meera Khan
Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Aug 11, 2000·JAMA : the Journal of the American Medical Association·E M AntmanE Braunwald
Mar 10, 2004·The New England Journal of Medicine·Christopher P CannonUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
Oct 30, 2004·American Heart Journal·E Magnus OhmanUNKNOWN CRUSADE Investigators
Jan 6, 2005·American Heart Journal·Hector O Ventura
Jan 27, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Ju Han KimJung Chaee Kang
Feb 26, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Ju Han KimJung Chaee Kang
Mar 17, 2005·European Heart Journal·Sigmund SilberUNKNOWN Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
Sep 16, 2005·The New England Journal of Medicine·Robbert J de WinterUNKNOWN Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators
Apr 28, 2006·JAMA : the Journal of the American Medical Association·Eric D PetersonE Magnus Ohman
Oct 24, 2006·The American Journal of Cardiology·Christine SavoyeUNKNOWN REmodelage VEntriculaire study group
Oct 26, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Akio OgawaTeruo Takano
Oct 26, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Hyungseop KimWee-Hyun Park
Nov 28, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Katsumi MiyauchiMasunori Matsuzaki
Dec 26, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Sang Hak LeeChong-Yun Rhim
Feb 27, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Sunao KojimaUNKNOWN Japanese Acute Coronary Syndrome Study (JACSS) Investigators
Apr 3, 2007·The American Journal of Cardiology·Rishi SukhijaJawahar L Mehta
Jun 26, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Raisuke IijimaMasato Nakamura
Jul 20, 2007·Circulation·David J Schneider, Burton E Sobel
Sep 22, 2007·The American Journal of Cardiology·Soko SetoguchiWolfgang C Winkelmayer

❮ Previous
Next ❯

Citations

Oct 18, 2015·International Journal of Cardiology·Mark Y ChanYoung-Hoon Jeong
Nov 8, 2014·The Korean Journal of Internal Medicine·Hyun Kuk KimYoung Jo Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.